{"name":"Chen Ying","slug":"chen-ying","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE9oaGt2bFFHT2NvS3MzaS1MYUNEaXpVeDZtLW1LTG9PUHV5dVpqS3ZMQWFrTDA0SUJSV1ZYZ2dHdkM1bUJlZVNWX1FFby1XN1p0UDBCLVJXUnAtSVA5LXJDb0JSVDdQWDBuazNWanVhVDJBOEdQTjU1dVNB?oc=5","date":"2026-04-03","type":"pipeline","source":"Taipei Times","summary":"Measures to help pharma firms amid tariff threats - Taipei Times","headline":"Measures to help pharma firms amid tariff threats","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNV0ZZVFE1MmVpeUpxaFhBT2lYaXBGczNOVHM5WC1jTllqX09yYlhsMlZRcUVsUk9OQThsN2x6NzNRdmI5UkJBRUFmc0ZYZHdrVlE3VEVwOTgwRTROMjhrSGgxeEE0RXpCOVZvNXlkU2wxZGtMZVVuM2hBTGJ1V2sxaE94TktRSVR5LXpvb1YyRHZCa2t4WHpFeUVaZWZ2cUtiLW1JSEJBQ1VuWFk?oc=5","date":"2025-11-19","type":"pipeline","source":"Healthcare Asia Magazine","summary":"China's licensing boom reshapes global pharma power - Healthcare Asia Magazine","headline":"China's licensing boom reshapes global pharma power","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxON2E4TVVSbTBvX05McFBjRjZtRXVaNmc0VjdjVC01OE56MzBpN1NCU0Z6R2pZLV9GenM1Q3FWcmdTREJXY3dqYTJFaW1zc2dlaXN4NXVFbHBWVVNBU0VaWGxSWlBzRHczc09EQUN5b295MEUyaGViMmZYTmtwZmtqSUpEUFh2eXZEMVAwbE1ZQ2FpaFVG?oc=5","date":"2025-09-15","type":"trial","source":"Frontiers","summary":"Technological and industrial trends in China’s pharmaceutical sector - Frontiers","headline":"Technological and industrial trends in China’s pharmaceutical sector","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE5iaVU3c3M5Q0hRQjR4WlVWTWZ4OU15VzNhTVRId2tZa2tGX1BFWFB4TUU2VTZ5QXRlZC0xWFNzWmk3d05KckxRZmRySnJYdkNRVXBVdkFpQ0hTamxYUlBMUEdVMlZRSy1n?oc=5","date":"2025-08-08","type":"pipeline","source":"Wiley Online Library","summary":"Population Pharmacokinetics of Busulfan in Pediatric Patients: Optimization of a Four-Times-Daily Dosing Regimen Based on EBMT Recommendations - Wiley Online Library","headline":"Population Pharmacokinetics of Busulfan in Pediatric Patients: Optimization of a Four-Times-Daily Dosing Regimen Based o","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxQQnBlWXlrQzN3Q1BNSFc5LXpwUDZqV1EwZzJFa1NjRlFCejNfX0syNS1pZFNzektZZC05eWwtWl9lY3FaNzdVRzJfZ3pJenN2WkJRNmE0bjltdjd3d2N6Y2ZWV1JfaFZXV3hHX1JwNUppTk5nQ2RDZTI5RnpVLUVWdmxWYTBZc0l0aFhKbnRMZUZVOW1DOUl2STNmVW43SjljTVAwQmVEMExXc3RweXhJVEIxdm1NT05ad1k3R3JMczlyOU94amJ1SW5FWlllSlNsQkh0bTBwQWstUUFEUThvZm53?oc=5","date":"2025-02-17","type":"pipeline","source":"European Pharmaceutical Review","summary":"Water-based reactors offer pharmaceutical industry a safer alternative to toxic solvents - European Pharmaceutical Review","headline":"Water-based reactors offer pharmaceutical industry a safer alternative to toxic solvents","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPa3hmQXlaUGV2YTBuT3ZyMFg0TTA1YlVTX3FfbzlxM25SZmpwTk1pQzEzSk9PdjBwYmctOWZKZFZ4TUZTeTdpc20tcWUyaWpEYmFzbm5qR3FmT2ZvWVFCNVc1cVpSMjhjSi03bkh1ZHJaVDU1eG9NdkQxSDZGdjNTelppLWd6Sm5wRTk0bVB2RWhQc0RIZ2R3eGR0NEI?oc=5","date":"2025-02-10","type":"pipeline","source":"Rice University","summary":"Rice scientists create tiny, water-based reactors for green chemistry - Rice University","headline":"Rice scientists create tiny, water-based reactors for green chemistry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9aSE54TGliR2tHdHVud3lWYjRrb3R0bjhEcUZheFpNRGVoUUVwV29UckFoTXpjZHpvd3phMmxiZHdZT0g4T2JwVEFlRlp5SUczMlpLLV8wdEdsYm1ZbldF?oc=5","date":"2025-01-14","type":"earnings","source":"nature.com","summary":"Nanocarrier imaging at single-cell resolution across entire mouse bodies with deep learning - nature.com","headline":"Nanocarrier imaging at single-cell resolution across entire mouse bodies with deep learning","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOdXV3N3pILUh0b0dwc1ZVQWRNb2ZYVkZ3ejQ0Vnh6ZXcxdExhbE1TZXk2U3N1aGdxT3VadUZkeGFxLUgtcENaUUpvS2NQdWo0Z25QYlhPVWNPV3ZYM2VjdmgwVkN3Y2tjTFJKNUJhVThIaFZ5cWY2ZDRtVGFvQ2FSRE1SM0FmN3RJb2ctQzlNS0c?oc=5","date":"2024-06-14","type":"pipeline","source":"ScienceDirect.com","summary":"Journal of Pharmaceutical Analysis - ScienceDirect.com","headline":"Journal of Pharmaceutical Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTFB2QjlBOTVrQ2Y3eFBhRV9DRnY5YURHSVdUSVROLUU2dEY0YnR5VkdLYi1pSkZmM2dnekJiMEpQX1M2RllTYy1ROGhrQTBJQVJ3RXVnMDYyY3FHaWwwR3FCTg?oc=5","date":"2023-12-27","type":"pipeline","source":"NEJM","summary":"Dual Antiplatelet Treatment up to 72 Hours after Ischemic Stroke - NEJM","headline":"Dual Antiplatelet Treatment up to 72 Hours after Ischemic Stroke","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQRlRFY01KWXJWdk9DN21RVEZlanhBWDlsNEx6Slk0Y3ZXY3RibGpQVzUwSDJiQW1hOWo4ZnNWT2ZJdnFwbDFVdHBpMzBhalg5Q0s3b21BeEtyMlI3WkVBX0VJTkdhcWlFdHlLaEZyTl8wY3ZDNXBZUDg5XzFyYkd0bF92Rm41bzhfbzIzTlUzRWJCUC0yY2p4WXdkdmxLNHNBS29jZDMwYzcySllSbHBPYVJla25rS1FVZ3FZWEF3?oc=5","date":"2023-09-28","type":"pipeline","source":"wsgr.com","summary":"Wilson Sonsini Advises Azurity on IP Matters Related to Slayback Pharma Acquisition - wsgr.com","headline":"Wilson Sonsini Advises Azurity on IP Matters Related to Slayback Pharma Acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxOQURVdkZ5MEdMdWYtMlhRYjhsaGhFeGdKYlBUSnlpVDdVS3RLb3ZILWJzZUFtQVNlZW56T0h0Z3pkSWpqUWRGR2dPZjJhODBpN2wyaVlQd19BU1ZpMVh3WWJtMHczcHFIT2ItY1d2QXJsRGVlOFdJbjIwOFd0RzdlYkVldWlqZlBiUENhWWpRUHV3MU9SNUNUUHF0N3V2NjQ?oc=5","date":"2021-06-07","type":"patent","source":"McKinsey & Company","summary":"An inflection point for biosimilars - McKinsey & Company","headline":"An inflection point for biosimilars - McKinsey & Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE9jajhQaXpyN0lHVDEtTGZkajNhVV9LNDBrLXBHVlVrcXQwSmg5Yjc5OVd1N0I1aFpaUHNjbjJGbVUwY0NmZERTX1FIR3JxUExwUm5JRmJfQVpucEk?oc=5","date":"2021-05-12","type":"pipeline","source":"EurekAlert!","summary":"Acta Pharmaceutica Sinica B Volume 11, Issue 4 publishes - EurekAlert!","headline":"Acta Pharmaceutica Sinica B Volume 11, Issue 4 publishes - EurekAlert!","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}